Q1 2020 Holdings
Filed 2020-05-15 | 73 holdings | $191.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $85.6M | 2,950,000 | 44.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $29.4M | 500,000 | 15.3% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $28.2M | 250,000 | 14.7% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $15.4M | 2,105,846 | 8.0% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $14.3M | 796,429 | 7.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $10.5M | 80,000 | 5.5% |
| Arcturus Therapeutics Hldg I(ARCT) | COM | 03969T109 | $3.6M | 262,037 | 1.9% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $2.9M | 479,988 | 1.5% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $257.8K | 1,000,000 | 0.1% |
| Turning Point Therapeutics I | COM | 90041T108 | $136.5K | 3,056,797 | 0.1% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $124.7K | 2,100,000 | 0.1% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $81.4K | 2,025,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $74.1K | 825,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $70.3K | 487,206 | 0.0% |
| Viela BIO Inc(VIE) | COM | 926613100 | $67.0K | 1,762,500 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $65.3K | 850,000 | 0.0% |
| Constellation Pharmaceuticals I(CNST) | COM | 210373106 | $64.1K | 2,040,021 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $60.7K | 2,266,108 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $60.6K | 2,767,078 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $53.9K | 1,100,000 | 0.0% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $45.2K | 1,732,200 | 0.0% |
| Ascendis Pharma A S(ASND)Call | SPONSORED ADR | 04351P101 | $39.4K | 350,000 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $39.2K | 1,709,765 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR)Call | COM | 60468T105 | $38.4K | 500,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR)Call | CL A | 75615P103 | $36.1K | 250,000 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $33.7K | 2,523,700 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $32.8K | 700,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $29.8K | 12,174,486 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $29.8K | 875,551 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $27.6K | 743,400 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $26.7K | 630,400 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $26.3K | 450,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR)Call | COM | 16383L106 | $25.1K | 625,000 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $24.8K | 700,000 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $23.9K | 426,104 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $21.9K | 1,568,550 | 0.0% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $21.0K | 687,149 | 0.0% |
| Axonics Modulation Technolog(AXNX*) | COM | 05465P101 | $20.3K | 800,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $19.7K | 98,603 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $19.6K | 2,600,000 | 0.0% |
| Immunovant Inc | UNIT 12/18/2024 | 45258J201 | $19.4K | 1,078,380 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $19.3K | 877,975 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $17.4K | 808,382 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $15.7K | 1,107,900 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $14.9K | 289,092 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $14.7K | 150,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $14.4K | 350,000 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $13.6K | 642,539 | 0.0% |
| Quotient LTD | SHS | G73268107 | $12.5K | 3,161,500 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $11.9K | 250,000 | 0.0% |